Clinical Trial: POTS Adrenergic Ab (CIHR Aims #1&2)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: The Pathophysiological Role of Adrenergic Antibodies in Postural Tachycardia Syndrome (Aims #1&2)

Brief Summary: Objective: In this pilot study, we will test the hypothesis that patients with POTS (age 18-60 years) will have a higher percentage of functional antibodies to adrenergic receptors compared with control subjects without POTS.